General News
Published December 14, 2020
Premera Blue Cross is following state and federal guidance, along with recommendations from the FDA and CDC, for administration of a COVID-19 vaccine. Our members’ health and safety is of the utmost importance to us. We encourage our members to follow preventive health guidelines, and that includes getting the appropriate vaccines. Check our COVID FAQ for the latest information and links to government COVID-19 sites.
We’ve recently updated our COVID-19 FAQ to include the latest information about the COVID-19 vaccine. Here is what you will want to know:
- There are several vaccines that have made it through all the required trials with little to no side effects and a high percentage of effectiveness.
- Both Moderna and Pfizer vaccines are expected before the end of the year.
- Vaccines made by AstraZeneca and Johnson and Johnson are expected in the first quarter of 2021.
- The FDA Vaccine Advisory Committee (VAC) is meeting in early December to discuss the submitted vaccines. If the VAC votes in favor, the FDA may accept the recommendation and issue an Emergency Use Authorization (EUA).
- Vaccine distribution can begin after an EUA is approved. The FDA and CMS have indicated distribution could begin as early as mid-December.
We will keep you informed
Each state has submitted an advisory plan for distribution of the vaccine. For more detailed information about COVID-19 vaccines and vaccine trials, visit our COVID-19 FAQ.
You can also check out the resources at the CDC and CMS:
The Washington state draft plan for COVID-19 vaccine preparedness addresses a variety of topics, including phases of distribution and allocation, identification of critical populations, and the initial plan for prioritization of administration to different groups.
Stay tuned for more information and resources from Premera. We will help you stay informed on future vaccine updates and help you share important information about getting vaccinated with your workforce.